| Work productivity outcomes associated with ocrelizumab compared with other disease-modifying therapies for multiple sclerosis EE Neuberger, IM Abbass, E Jones, NJ Engmann Neurology and Therapy 10, 183-196, 2021 | 18 | 2021 |
| Cost-effectiveness of cannabidiol adjunct therapy versus usual care for the treatment of seizures in Lennox-Gastaut syndrome EE Neuberger, JJ Carlson, DL Veenstra Pharmacoeconomics 38, 1237-1245, 2020 | 12 | 2020 |
| Economic value of pharmacogenetic testing for cancer drugs with clinically relevant drug-gene associations: a systematic literature review F Faruque, H Noh, A Hussain, E Neuberger, E Onukwugha Journal of managed care & specialty pharmacy 25 (2), 260-271, 2019 | 11 | 2019 |
| Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA M Dehghan, G Wong, E Neuberger, C Kin, F Rieder, KT Park BMJ Open Gastroenterology 8 (1), e000781, 2021 | 8 | 2021 |
| Baloxavir vs oseltamivir: reduced utilization and costs in influenza. E Neuberger, C Wallick, D Chawla, R de Cassia Castro American Journal of Managed Care 28 (3), 2022 | 5 | 2022 |
| 1345. Patient perspectives and journey with influenza and seeking care from US National Survey N Way, A Martin, C Wallick, E Neuberger, M Corral Open Forum Infectious Diseases 8 (Suppl 1), S759, 2021 | 3 | 2021 |
| Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer PA Kaufman, E Neuberger, NRM Schwartz, S Wang, Y Liu, LI Hsu, ... Frontiers in Oncology 13, 1264861, 2023 | 2 | 2023 |
| Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer. CK Anders, E Neuberger, NRM Schwartz, K Bartley, LI Hsu, G Wong, ... Journal of Clinical Oncology 41 (16_suppl), 1051-1051, 2023 | 2 | 2023 |
| Authors’ reply to Comment on “Cost-effectiveness of cannabidiol adjunct therapy versus usual care for the treatment of seizures in Lennox-Gastaut syndrome” EE Neuberger, JJ Carlson, DL Veenstra PharmacoEconomics 39 (4), 477-478, 2021 | 2 | 2021 |
| Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016‐2019 EE Neuberger, TM To, A Seetasith, SM Arndorfer, CJ Wallick ACR Open Rheumatology 4 (7), 631-639, 2022 | 1 | 2022 |
| Minimal Clinically Important Difference (MCID) Estimates for the University of California, San Diego Shortness of Breath Questionnaire (UCSD-SOBQ) in Patients with Idiopathic … KI Aronson, G Raghu, S Gupta, J Ko, D Kile, E Neuberger, J Devine, ... AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 205, 2022 | 1 | 2022 |
| PND20 COST-UTILITY OF CANNABIDIOL IN ADDITION TO BACKGROUND THERAPY VERSUS BACKGROUND THERAPY ALONE IN LENNOX-GASTAUT SYNDROME E Neuberger, DL Veenstra Value in Health 22, S273, 2019 | 1 | 2019 |
| Real-world clinical outcomes in patients with HER2+ metastatic breast cancer receiving tucatinib therapy after 2 or more prior HER2-directed therapies C Anders, E Neuberger, K Bartley, B Pittner, A Sow, S Wang, P Kaufman European Journal of Cancer 200, 2024 | | 2024 |
| Abstract P4-03-30: Patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer PA Kaufman, E Neuberger, LI Hsu, N Schwartz, K Bartley, S Wang, Y Liu, ... Cancer Research 83 (5_Supplement), P4-03-30-P4-03-30, 2023 | | 2023 |
| Burden of illness in metastatic colorectal cancer. E Neuberger, N Schwartz, LI Hsu, A Dillon, MF Siadak Journal of Clinical Oncology 41 (4_suppl), 53-53, 2023 | | 2023 |
| 801. Patient Reported Experience with Influenza Episode and Impact on Life and Work N Way, A Martin, C Wallick, E Neuberger, M Corral Open Forum Infectious Diseases 8 (Suppl 1), S495, 2021 | | 2021 |
| Antiviral Use and Healthcare Resource Utilization Among Patients with Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016-2019 E Neuberger, TM To, A Seetasith, S Arndorfer, C Wallick ARTHRITIS & RHEUMATOLOGY 73, 273-274, 2021 | | 2021 |
| Sa546 WORSE OUTCOMES AND HIGHER COSTS OF CARE FOR PATIENTS WITH FIBROSTENOTIC CROHN'S DISEASE: A REAL-WORLD PROPENSITY-MATCHED ANALYSIS IN THE USA M Dehghan, G Wong, E Neuberger, C Kin, F Rieder, KT Park Gastroenterology 160 (6), S-544-S-545, 2021 | | 2021 |
| 1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization E Neuberger, C Wallick, D Chawla, R de Cassia Castro Open Forum Infectious Diseases 7 (Suppl 1), S761, 2020 | | 2020 |
| Cannabidiol in Lennox-Gastaut syndrome: modest benefits at high cost EE Neuberger PharmacoEconomics & Outcomes News 859, 7-8, 2020 | | 2020 |
